Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.36 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.39 |
| ▸ | LDHB | P07195 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL2494054 | 1.00 | CA1 (0.40) | CA1CA2CA9LDHALDHB | |
| Water SCHEMBL28807144 | 1.00 | CA1 (0.40) | CA1CA2CA9LDHALDHB | |
| SCHEMBL57216 | 0.94 | CA1 (0.44) | CA1CA2CA9LDHALDHB | |
| SCHEMBL57215 | 0.94 | CA1 (0.44) | CA1CA2CA9LDHALDHB | |
| SCHEMBL48638 | 0.94 | CA1 (0.44) | CA1CA2CA9LDHALDHB | |
| Ammonia Solution, Strong SCHEMBL11646225 | 0.89 | CA1 (0.40) | CA1CA2CA9LDHALDHB | |
| Ammonia Solution, Strong SCHEMBL11646230 | 0.89 | CA1 (0.40) | CA1CA2CA9LDHALDHB | |
| SCHEMBL27658054 | 0.89 | CA1 (0.40) | CA1CA2CA9LDHALDHB | |
| Ammonia Solution, Strong SCHEMBL11646218 | 0.89 | CA1 (0.40) | CA1CA2CA9LDHALDHB | |
| SCHEMBL5138395 | 0.89 | CA1 (0.40) | CA1CA2CA9LDHALDHB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680375-A1 | SYSTEM AND METHOD FOR FLUID CAPTURE | GE Vernova Technology GmbH (CH) | 2026-01-21 | — | — | EP | disclosed |
| EP-4680252-A1 | SYSTEM AND METHOD FOR FLUID CAPTURE | GE Vernova Infrastructure Technology LLC (US) | 2026-01-21 | — | — | EP | disclosed |
| WO-2024232943-A1 | SYSTEM AND METHOD FOR FLUID CAPTURE | GE INFRASTRUCTURE TECHNOLOGY LLC (US) | 2024-11-14 | — | — | WO | disclosed |
| WO-2024232944-A1 | SYSTEM AND METHOD FOR FLUID CAPTURE | GE INFRASTRUCTURE TECHNOLOGY LLC (US) | 2024-11-14 | — | — | WO | disclosed |
| CN-116375615-A | Preparation method of florfenicol amine, intermediate thereof and preparation method thereof | 弈柯莱生物科技(上海)股份有限公司 | 2023-07-04 | — | — | CN | disclosed |
| EP-2555742-B2 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2018-12-05 | — | — | EP | disclosed |
| EP-2756065-B1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2018-10-24 | — | — | EP | disclosed |
| US-9890351-B2 | Encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2018-02-13 | — | — | US | disclosed |
| EP-2741731-B1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2017-05-17 | — | — | EP | disclosed |
| US-9644174-B2 | Encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2017-05-09 | — | — | US | disclosed |
| US-20130061883-A1 | ENCAPSULATES | PROCTER & GAMBLE COMPANY, THE | 2013-03-14 | — | — | US | disclosed |
| US-20130039962-A1 | ENCAPSULATES | ENCAPSYS, LLC | 2013-02-14 | — | — | US | disclosed |
| WO-2013022949-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2013-02-14 | — | — | WO | disclosed |
| EP-2555742-A1 | ENCAPSULATES | The Procter & Gamble Company (US) | 2013-02-13 | — | — | EP | disclosed |
| WO-2011127030-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2011-10-13 | — | — | WO | disclosed |
| US-20110245136-A1 | ENCAPSULATES | PROCTER & GAMBLE COMPANY, THE | 2011-10-06 | — | — | US | disclosed |
| US-7629400-B2 | Image making medium | HYMAN SYDNEY | 2009-12-08 | — | — | US | disclosed |
| US-20030035917-A1 | Image making medium | HYMAN SYDNEY (US) | 2003-02-20 | — | — | US | disclosed |
| EP-0244055-A2 | Method of sequencing peptides | BIO-AFFINITY SYSTEMS, INC. (US) | 1987-11-04 | — | — | EP | disclosed |
| US-4665037-A | Method of sequencing peptides | ANALYTICHEM INTERNATIONAL, INC. (US) | 1987-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130039962-A1 | ENCAPSULATES | ABCB4, PPIB, FLNB | THRB 4585/4885ACHE 279/4885CA1 1026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.